RegenaLung

RegenaLung is a clinical-stage biotechnology and medical device company focused on lung regeneration and the treatment of chronic respiratory diseases. As a startup within the Leonhardt Ventures accelerator ecosystem, the company utilizes a proprietary platform that combines bioelectric stimulation with biologics to promote tissue repair and recovery. Its technology triggers the controlled, sequential release of regenerative proteins—such as SDF-1, VEGF, and IGF-1—to recruit a patient's own stem cells and repair damaged lung tissue. RegenaLung targets a range of indications including COPD, ARDS, and lung cancer through its specialized micro-stimulators and implantable micro-pumps. The company aims to provide a regenerative alternative to traditional treatments for failing lung function.